Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl. 2011;8(1):2–7.
Johansen KL, Chertow GM, Foley RN, et al. US renal data system 2020 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;77(4 Suppl 1):A7–8.
Aboelnasr MS, Shaltout AK, AlSheikh MR, Abdelhameed AH, Elrefaey W. Diabetic kidney disease in patients newly diagnosed with type-2 diabetes mellitus: incidence and associations. Saudi J Kidney Dis Transpl. 2020;31(1):191–9.
Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes. BMC Nephrol. 2020;21(1):167.
Article PubMed PubMed Central Google Scholar
American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of care in diabetes-2025. Diabetes Care. 2025;48(1 Suppl 1):S239–51.
de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075–90.
Article PubMed PubMed Central Google Scholar
Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Community Health. 2021;12: 21501327211003683.
Article PubMed PubMed Central Google Scholar
Lin CH, Chang YC, Chuang LM. Early detection of diabetic kidney disease: present limitations and future perspectives. World J Diabetes. 2016;7(14):290–301.
Article PubMed PubMed Central Google Scholar
Gutiérrez-Peredo GB, Montaño-Castellón I, Gutiérrez-Peredo AJ, et al. The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective study. BMC Nephrol. 2024;25(1): 418.
Article PubMed PubMed Central Google Scholar
Mann SJ, Gerber LM. Addressing the problem of inaccuracy of measured 24-hour urine collections due to incomplete collection. J Clin Hypertens (Greenwich). 2019;21(11):1626–34.
Article PubMed PubMed Central Google Scholar
Boyd C, Wood K, Whitaker D, et al. Accuracy in 24-hour urine collection at a tertiary center. Rev Urol. 2018;20(3):119–24.
PubMed PubMed Central Google Scholar
Hogan MC, Reich HN, Nelson PJ, et al. The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int. 2016;90(5):1080–9.
Article PubMed PubMed Central Google Scholar
Mendelson L, Sanchorawala V, Connors L, et al. Correlation between 24-hour urine protein and random urine protein-creatinine ratio in amyloid light-chain amyloidosis. Kidney Med. 2022;4(4): 100427.
Article PubMed PubMed Central Google Scholar
Vučić Lovrenčić M, Božičević S, Smirčić Duvnjak L. Diagnostic challenges of diabetic kidney disease. Biochem Med (Zagreb). 2023. https://doi.org/10.11613/BM.2023.030501.
Article PubMed PubMed Central Google Scholar
Li X, Wang Y. Associations of the TyG index with albuminuria and chronic kidney disease in patients with type 2 diabetes. PLoS ONE. 2024;19(10): e0312374.
Article PubMed PubMed Central Google Scholar
Wang H, Chen G, Sun D, Ma Y. The threshold effect of triglyceride glucose index on diabetic kidney disease risk in patients with type 2 diabetes: unveiling a non-linear association. Front Endocrinol (Lausanne). 2024;15: 1411486.
Article PubMed PubMed Central Google Scholar
Sun Q, Zhao M, Wang X, et al. The predictive value of insulin resistance surrogates for diabetic kidney disease in type 2 diabetes mellitus. Diabetes Ther. 2025;16(8):1649–63.
Article PubMed PubMed Central Google Scholar
Jiang Y, Lai X. Association between the triglyceride glucose index, triglyceride-glucose body mass index and diabetic kidney disease in adults with newly diagnosed type 2 diabetes. Front Med (Lausanne). 2024;11:1328601.
Article PubMed PubMed Central Google Scholar
Zhang R, Hong J, Wu Y, Lin L, Chen S, Xiao Y. Joint association of triglyceride glucose index (TyG) and a body shape index (ABSI) with stroke incidence: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1): 7.
Article PubMed PubMed Central Google Scholar
Jihong S, Xiaojie C, He L, Yifan Z. Association between the triglyceride glucose index and atherosclerotic cardiovascular disease in the general population: analysis of the national health and nutrition examination survey 1999-2004. Front Endocrinol (Lausanne). 1999;15: 1376357.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
Khamseh ME, Malek M, Abbasi R, Taheri H, Lahouti M, Alaei-Shahmiri F. Triglyceride glucose index and related parameters (triglyceride glucose-body mass index and triglyceride glucose-waist circumference) identify nonalcoholic fatty liver and liver fibrosis in individuals with overweight/obesity. Metab Syndr Relat Disord. 2021;19(3):167–73.
Malek M, Khamseh ME, Chehrehgosha H, Nobarani S, Alaei-Shahmiri F. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocr Res. 2021;74(3):538–45.
He HM, Xie YY, Chen Q, et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1): 69.
Article PubMed PubMed Central Google Scholar
Zhang H, Wang L, Zhang Q, et al. Non-linear association of triglyceride-glucose index with cardiovascular and all-cause mortality in T2DM patients with diabetic kidney disease: NHANES 2001-2018 retrospective cohort study. Lipids Health Dis. 2001;23(1): 253.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–276.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.
Article PubMed PubMed Central Google Scholar
Zeng G, You D, Ye L, et al. n-3 PUFA poor seafood consumption is associated with higher risk of gout, whereas n-3 PUFA rich seafood is not: NHANES 2007-2016. Front Nutr. 2007;10: 1075877.
MacGregor KA, Gallagher IJ, Moran CN. Relationship between insulin sensitivity and menstrual cycle is modified by BMI, fitness, and physical activity in NHANES. J Clin Endocrinol Metab. 2021;106(10):2979–90.
Article PubMed PubMed Central Google Scholar
Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2001;22(1): 279.
Song Y, Hwang JA, Shin J, et al. Waist-hip ratio measured by bioelectrical impedance analysis as a valuable predictor of chronic kidney disease development. BMC Nephrol. 2022;23(1): 349.
Article PubMed PubMed Central Google Scholar
Anoop S, Krakauer J, Krakauer N, Misra A. A Body shape index significantly predicts MRI-defined abdominal adipose tissue depots in non-obese Asian Indians with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2020;8(1): e001324.
Article PubMed PubMed Central Google Scholar
Lee H, Chung HS, Kim YJ, et al. Association between body shape index and risk of mortality in the United States. Sci Rep. 2022;12(1): 11254.
Article PubMed PubMed Central Google Scholar
Kataoka H, Nitta K, Hoshino J. Visceral fat and attribute-based medicine in chronic kidney disease. Front Endocrinol (Lausanne). 2023;14: 1097596.
Comments (0)